pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
996
stories
3h
Opinion: The U.S. lost measles elimination status. The next Congress should help restore it
stat
3h
Study raises doubts about combining vaccine, monoclonal antibody to protect against malaria
stat
9h
Novartis projects slowed growth, pins hopes on billions in pipeline potential
biospace
10h
Novartis details eczema win, autoimmune CAR-T efforts after rocky quarter
endpoints
10h
nChroma halves workforce, BioXcel lets execs go
biospace
10h
Regeneron racks up another first as FDA greenlights generalized myasthenia gravis RNA drug
biospace
11h
With FDA nod, Regeneron brings an RNAi drug to autoimmune disease
biopharma dive
11h
Regeneron enters neurology field as FDA approves siRNA for myasthenia gravis
endpoints
16h
Vaccine biotech Evaxion halts infectious disease, autoimmune work to focus on oncology
fiercebiotech
16h
nChroma halves headcount, calls time on trial of potential HBV ‘cure’
fiercebiotech
21h
Grand Strand Sandwich Company Recalls Lunch Box Bacon Egg and Cheese Biscuit, Lunch Box Jumbo Sausage Biscuit, Lunch Box Sausage Egg and Cheese Biscuit, Lunch Box Chicken Sausage Biscuit Due to Listeria Monocytogenes Contamination
fda recalls
21h
9 biotechs will cut at least half their California workforces
biospace
1d
Pfizer leaps into ‘in vivo’ CAR-T with latest China deal
biopharma dive
1d
FDA publishes rejection letter for Summit drug; Nuvalent buyout pays more dividends for GSK
biopharma dive
1d
Pfizer launches into autoimmune CAR T with China's Starna in up to $2.6B deal
biospace
1d
Summit’s rejection letter reveals FDA’s deeper concerns about trial design, safety
biospace
1d
Pfizer gets into in vivo CAR-T through licensing deal with Starna Therapeutics
endpoints
1d
Pfizer enters in vivo CAR-T space via 3-program, $2.6B deal with China’s Starna
fiercebiotech
1d
5 acquisitions that forced Big Pharmas to co-parent
biospace
1d
At Fierce’s London event, Big Pharmas tell biotechs to ‘be transparent’ to secure deals
fiercebiotech
2d
Larbi Inc. Recalls Yellow Dock Root Because of Possible Health Risk
fda recalls
2d
Fresh & Ready Foods LLC Expands Recall to Include Fresh to You Brand Sausage, Egg & Cheese Biscuit Sandwich and Meals Made in Minutes Brand Biscuit & Sausage Gravy Due to Possible Health Risk
fda recalls
2d
Isomorphic Labs breaks biotech VC fundraising record with $5B series C
biospace
2d
AI drugmaker Isomorphic restocks with $5B fundraise
biopharma dive
2d
Vertex on the verge of ‘iconic’ evolution as key kidney disease verdict looms
biospace
2d
Sellas’ cancer vaccine slashes death risk by 41% in late-stage AML study
biospace
2d
NIH’s infectious disease unit has a new head at last
stat
2d
Isomorphic Labs raises $5B series C months after $2.1B round
fiercebiotech
3d
CG Oncology drug delivers ‘exceptional’ results in key bladder cancer trial
biopharma dive
3d
Lilly’s early-stage M&A quest finds $1.5B deal for Calytrix’s blood cancer work
biospace
← prev
page 1 of 34
next →